Skip to main content

Compugen Ltd

CGEN
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001119774

In the last 90 days, Compugen Ltd insiders filed 0 open-market purchases and 1 sale; 83 institutions reported holding it in 13F filings for Q2 2026, worth $30.3M in total; ARK Invest is the only superinvestor holding it.

Q3 2022 vs. Q2 2022

How the institutions holding Compugen Ltd changed between Q2 2022 and Q3 2022.

All holders in Q3 2022All holders in Q2 2022

13F holders of CGEN: Q2 2022 compared with Q3 2022
MeasureQ2 2022Of which not filed for Q3 2022Q3 2022Change
Holders90181−8
Shares37.9M15.1K22.0M−15.9M (−42.0%)
Value$70.1M$32.0K$14.5M−$55.6M (−79.3%)

1 institution that held it in Q2 2022 haven't filed for Q3 2022 yet. Not filing isn't selling, so the changes leave them out.

New holders (11)

Institutions that held Compugen Ltd at the end of Q3 2022 but not at the end of Q2 2022.

Institutions new to CGEN in Q3 2022
InstitutionSharesValue% of portfolio
Davidson Kempner Capital Management LP1,900,000$1.30M0.03%
D. E. Shaw & Co., Inc.89,078$59.0K0.00%
Two Sigma Securities, LLC36,251$24.0K0.00%
Virtu Financial LLC35,939$24.0K0.00%
Acadian Asset Management LLC25,393$16.0K0.00%
HRT Financial LP25,020$16.0K0.00%
Ground Swell Capital, LLC15,388$10.0K0.03%
Mariner, LLC11,987$8.00K0.00%
JustInvest LLC12,043$8.00K0.00%
China Universal Asset Management Co., Ltd.811$1.00K0.00%
Bogart Wealth, LLC100$00.00%

Sold out (19)

Institutions that held Compugen Ltd at the end of Q2 2022 and filed for Q3 2022 without it.

Not filed for Q3 2022 yet (1)

Institutions that held Compugen Ltd at the end of Q2 2022 and haven't filed a 13F for Q3 2022. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding CGEN in Q2 2022 that haven't filed for Q3 2022
InstitutionShares, Q2 2022Value, Q2 2022
HighPoint Advisor Group LLC15,149$32.0K